The Cost-effectiveness of Celecoxib versus Non-steroidal Anti-inflammatory Drugs plus Proton-pump Inhibitors for Treating Osteoarthritis in Algeria

Nadir Hammoumraoui; Sid Ahmed Kherraf; Joaquin Mould-Quevedo; Tarek A. Ismail

Loading [Contrib]/a11y/accessibility-menu.js

This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

JHEOR

Articles
For Authors
Editorial Board
About
Issues
Blog
Journal Policies
For Reviewers

search
X (formerly Twitter) (opens in a new tab)
Bluesky (opens in a new tab)
LinkedIn (opens in a new tab)
RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:3023/feed

ISSN 2327-2236

Autoimmune Diseases

Vol. 1, Issue 2, 2013

October 07, 2013 EDT

The Cost-effectiveness of Celecoxib versus Non-steroidal Anti-inflammatory Drugs plus Proton-pump Inhibitors for Treating Osteoarthritis in Algeria

Nadir Hammoumraoui, Sid Ahmed Kherraf, Joaquin Mould-Quevedo, Tarek A. Ismail,

proton-pump inhibitorsalgeriacost-effectivenessosteoarthritiscelecoxib

ccby-4.0

Photo by Larm Rmah on Unsplash

JHEOR

Hammoumraoui N, Kherraf SA, Mould-Quevedo J, Ismail TA. The Cost-effectiveness of Celecoxib versus Non-steroidal Anti-inflammatory Drugs plus Proton-pump Inhibitors for Treating Osteoarthritis in Algeria. JHEOR. 2013;1(2):184-199.

View more stats